Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer
1997

Detecting Mutant K-ras DNA in Blood of Colorectal Cancer Patients

Sample size: 59 publication Evidence: moderate

Author Information

Author(s): MS Kopreski, FA Benko, C Kwee, KE Leitzel, E Eskander, A Lipton, CD Gocke

Primary Institution: The Pennsylvania College University School of Medicine

Hypothesis

Can mutant K-ras DNA be detected in the plasma or serum of patients with colorectal cancer?

Conclusion

Mutant K-ras DNA is detectable in the plasma or serum of patients with advanced colorectal cancer, suggesting it could be used for monitoring and diagnosis.

Supporting Evidence

  • 39% of colorectal cancer patients had detectable mutant K-ras DNA in their blood.
  • All normal volunteers tested negative for mutant K-ras DNA.
  • Mutant K-ras DNA was confirmed by sequencing in positive samples.

Takeaway

Doctors can find a specific DNA change in the blood of people with colorectal cancer, which might help in spotting the disease early.

Methodology

A PCR assay was used to detect mutant K-ras DNA in blood samples from colorectal cancer patients and normal volunteers.

Limitations

The study primarily focused on patients with metastatic disease, and the applicability to early disease detection remains uncertain.

Participant Demographics

The study included 31 patients with metastatic or unresected colorectal cancer and 28 normal volunteers.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication